Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.73 |
| ▸ | RAB9A | P51151 | 4/20 | 0.73 |
| ▸ | MAPT | P10636 | 3/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7168347 | 0.95 | MAPT (0.71) | NPC1RAB9AMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL21100591 | 0.91 | MAPT (0.73) | NPC1RAB9AMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL9786970 | 0.91 | MAPT (0.74) | NPC1RAB9AMAPTSMN1; SMN2KMT2A | |
| SCHEMBL31357491 | 0.90 | MAPT (0.78) | NPC1RAB9AMAPTSMN1; SMN2ALDH1A1 | |
| Methoxymethane SCHEMBL27278268 | 0.89 | MAPT (0.73) | NPC1RAB9AMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL23906975 | 0.88 | NPC1 (0.62) | NPC1RAB9AMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL1068092 | 0.87 | MAPT (0.69) | NPC1RAB9AMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3732530 | 0.86 | NPC1 (0.69) | NPC1RAB9AMAPTSMN1; SMN2KMT2A | |
| SCHEMBL29446640 | 0.86 | MAPT (0.69) | NPC1RAB9AMAPTSMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL8136104 | 0.85 | MAPT (0.67) | NPC1RAB9AMAPTSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116159578-A | Iron catalyst for catalyzing oxidative cleavage of lignin model to produce phenol and ester and application thereof | 天津理工大学 | 2023-05-26 | — | — | CN | claimed |
| CN-115697053-A | Biocide composition | 巴斯夫欧洲公司 | 2023-02-03 | — | — | CN | claimed |
| CN-116375641-A | C3-phenoxy substituted quinoline compound and synthetic method and application thereof | 杭州师范大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-116159578-A | Iron catalyst for catalyzing oxidative cleavage of lignin model to produce phenol and ester and application thereof | 天津理工大学 | 2023-05-26 | — | — | CN | disclosed |
| US-9212199-B2 | Catalyst compounds | THE UNIVERSITY OF LIVERPOOL (GB) | 2015-12-15 | — | — | US | disclosed |
| US-9212199-B2 | Catalyst compounds | THE UNIVERSITY OF LIVERPOOL (GB) | 2015-12-15 | — | — | US | disclosed |
| US-20150080592-A1 | CATALYST COMPOUNDS | THE UNIVERSITY OF LIVERPOOL (GB) | 2015-03-19 | — | — | US | disclosed |
| US-20150080592-A1 | CATALYST COMPOUNDS | THE UNIVERSITY OF LIVERPOOL (GB) | 2015-03-19 | — | — | US | disclosed |
| WO-2013153407-A1 | CATALYST COMPOUNDS | THE UNIVERSITY OF LIVERPOOL (GB) | 2013-10-17 | — | — | WO | disclosed |
| US-20120074396-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-29 | — | — | US | disclosed |
| US-8115200-B2 | Electroactive materials | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-14 | — | — | US | disclosed |
| US-20020091264-A1 | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORPORATION | 2002-07-11 | — | — | US | disclosed |
| EP-1061921-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-12-27 | — | — | EP | disclosed |
| EP-1025090-A4 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2000-11-08 | — | — | EP | disclosed |
| EP-1025090-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SmithKline Beecham Corporation (US) | 2000-08-09 | — | — | EP | disclosed |
| WO-1999045927-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-09-16 | — | — | WO | disclosed |
| WO-1999015508-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-04-01 | — | — | WO | disclosed |
| US-5120783-A | Hydrotalcite, zinc compound, magnesium hydroxide and beta-diketone compound and/or phosphite compound; discoloration inhibition, radiation transparent and heat resistance | KYOWA CHEMICAL INDUSTRY CO., LTD. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0432495-A1 | Stabilized halogen-containing resin composition | KYOWA CHEMICAL INDUSTRY CO., LTD. (JP) | 1991-06-19 | — | — | EP | disclosed |
| US-4988662-A | MULTILAYER ELEMENT OF A COATED SUBSTRATE, A FILM WITH A COLOR-FORMING LACTONE, AN ACID AND A SENSITIZER | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091264-A1 | Vitronectin receptor antagonists | CALCR, ADGRF1, CALCRL | NPC1 1061/4885RAB9A 1860/4885MAPT 3004/4885 |
| US-20120074396-A1 | ELECTROACTIVE MATERIALS | KCNN4, RCOR3, HCN4 | NPC1 4025/4885RAB9A 1090/4885MAPT 4120/4885 |
| US-20150080592-A1 | CATALYST COMPOUNDS | IDH3B, IDH2, NQO1 | NPC1 2868/4885RAB9A 857/4885MAPT 4290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.